Switch to:
More From Other Websites
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioTime, Inc. for Potential... Jun 26 2017
BioTime, Inc. breached its 50 day moving average in a Bullish Manner : BTX-US : June 26, 2017 Jun 26 2017
Biotime Expands & Advances Ophthalmology Portfolio Jun 19 2017
BioTime’s Renevia® Achieves Primary Endpoint in European Pivotal Trial Jun 14 2017
BioTime's Renevia succeeds in pivotal European facial wasting trial Jun 14 2017
BioTime to Announce Top Line Data From the Company’s Renevia European Pivotal trial Jun 08 2017
ETFs with exposure to BioTime, Inc. : June 5, 2017 Jun 05 2017
BioTime, Inc. :BTX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Jun 02 2017
BioTime, Inc. breached its 50 day moving average in a Bearish Manner : BTX-US : May 29, 2017 May 29 2017
BioTime Co-CEO Dr. Michael West to Deliver Presentation as Part of Biotech Panel at Mauldin... May 23 2017
BioTime to Present at 16th National Life Sciences and Biotechnology Week (MIXiii BIOMED) May 23 2017
Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q1 May 11 2017
BioTime Presents Retinal Restoration Data at ARVO May 11 2017
BioTime posts 1Q profit May 10 2017
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments May 10 2017
Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised May 10 2017
Prothena (PRTA) Q1 Loss Narrower than Expected, Updates View May 10 2017
BioTime Announces New Positive Data from OpRegen® Trial in Dry-AMD May 09 2017
BioTime, Inc. : Undervalued relative to peers, but don’t ignore the other factors May 08 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK